SSB and GE sign worldwide supply agreement

Sartorius Stedim Biotech (SSB) and GE Healthcare’s Life Sciences business (GE), have entered into a worldwide OEM supply agreement for SSB’s membrane adsorber purification technology, Sartobind

Under the terms of the agreement, SSB will manufacture membrane adsorber technologies for GE which will be marketed as part of GE’s ReadyToProcess product offerings.

Membrane adsorber ion-exchange technology is used in the industry for the removal of contaminants such as endotoxins and viruses during the production of protein-based drugs and can offer manufacturers advantages compared to other techniques. 

Reinhard Vogt, executive vice president of marketing, sales and services, Sartorius Stedim Biotech, said: “This agreement with GE is exciting for the team at SSB and will further establish our innovative purification technologies into new applications, processes and platforms worldwide. “

Catarina Flyborg, BioProcess downstream product leader at GE Healthcare’s Life Sciences business, said: “The biopharmaceutical industry worldwide is facing increasing pressure to continually reduce costs, increase efficiency and improve quality. 

“Our vision is that an integrated manufacturing approach where every stage – from choice of cell culture media right through to selecting the best approach to purification – has the potential to improve product yields and reduce time to market.”

The new products will be marketed by GE under the brand “ReadyToProcess Adsorber”.